Template:PDB Gallery/1017

{{Gallery }}
 * lines=4
 * Image:PDB_1aq1_EBI.jpg|1aq1: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE
 * Image:PDB_1b38_EBI.jpg|1b38: HUMAN CYCLIN-DEPENDENT KINASE 2
 * Image:PDB_1b39_EBI.jpg|1b39: HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160
 * Image:PDB_1buh_EBI.jpg|1buh: CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1
 * Image:PDB_1ckp_EBI.jpg|1ckp: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B
 * Image:PDB_1di8_EBI.jpg|1di8: THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE
 * Image:PDB_1dm2_EBI.jpg|1dm2: HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE
 * Image:PDB_1e1v_EBI.jpg|1e1v: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058
 * Image:PDB_1e1x_EBI.jpg|1e1x: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027
 * Image:PDB_1e9h_EBI.jpg|1e9h: THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND
 * Image:PDB_1f5q_EBI.jpg|1f5q: CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2
 * Image:PDB_1fin_EBI.jpg|1fin: CYCLIN A-CYCLIN-DEPENDENT KINASE 2 COMPLEX
 * Image:PDB_1fq1_EBI.jpg|1fq1: CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
 * Image:PDB_1fvt_EBI.jpg|1fvt: THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH AN OXINDOLE INHIBITOR
 * Image:PDB_1fvv_EBI.jpg|1fvv: THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLE INHIBITOR
 * Image:PDB_1g5s_EBI.jpg|1g5s: CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717
 * Image:PDB_1gih_EBI.jpg|1gih: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
 * Image:PDB_1gii_EBI.jpg|1gii: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
 * Image:PDB_1gij_EBI.jpg|1gij: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR
 * Image:PDB_1gy3_EBI.jpg|1gy3: PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE
 * Image:PDB_1gz8_EBI.jpg|1gz8: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE
 * Image:PDB_1h00_EBI.jpg|1h00: CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
 * Image:PDB_1h07_EBI.jpg|1h07: CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
 * Image:PDB_1h08_EBI.jpg|1h08: CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
 * Image:PDB_1h0v_EBI.jpg|1h0v: HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R)-PYRROLIDINO-5'-YL]METHOXYPURINE
 * Image:PDB_1h0w_EBI.jpg|1h0w: HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE
 * Image:PDB_1h1p_EBI.jpg|1h1p: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058
 * Image:PDB_1h1q_EBI.jpg|1h1q: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094
 * Image:PDB_1h1r_EBI.jpg|1h1r: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086
 * Image:PDB_1h1s_EBI.jpg|1h1s: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102
 * Image:PDB_1h24_EBI.jpg|1h24: CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F
 * Image:PDB_1h25_EBI.jpg|1h25: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN
 * Image:PDB_1h26_EBI.jpg|1h26: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53
 * Image:PDB_1h27_EBI.jpg|1h27: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27
 * Image:PDB_1h28_EBI.jpg|1h28: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107
 * Image:PDB_1hck_EBI.jpg|1hck: HUMAN CYCLIN-DEPENDENT KINASE 2
 * Image:PDB_1hcl_EBI.jpg|1hcl: HUMAN CYCLIN-DEPENDENT KINASE 2
 * Image:PDB_1jst_EBI.jpg|1jst: PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A
 * Image:PDB_1jsu_EBI.jpg|1jsu: P27(KIP1)/CYCLIN A/CDK2 COMPLEX
 * Image:PDB_1jsv_EBI.jpg|1jsv: The structure of cyclin-dependent kinase 2 (CDK2) in complex with 4-[(6-amino-4-pyrimidinyl)amino]benzenesulfonamide
 * Image:PDB_1jvp_EBI.jpg|1jvp: Crystal structure of human CDK2 (unphosphorylated) in complex with PKF049-365
 * Image:PDB_1ke5_EBI.jpg|1ke5: CDK2 complexed with N-methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide
 * Image:PDB_1ke6_EBI.jpg|1ke6: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE
 * Image:PDB_1ke7_EBI.jpg|1ke7: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE
 * Image:PDB_1ke8_EBI.jpg|1ke8: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE
 * Image:PDB_1ke9_EBI.jpg|1ke9: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE
 * Image:PDB_1ogu_EBI.jpg|1ogu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR
 * Image:PDB_1oi9_EBI.jpg|1oi9: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
 * Image:PDB_1oiq_EBI.jpg|1oiq: IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
 * Image:PDB_1oir_EBI.jpg|1oir: IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
 * Image:PDB_1oit_EBI.jpg|1oit: IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION
 * Image:PDB_1oiu_EBI.jpg|1oiu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
 * Image:PDB_1oiy_EBI.jpg|1oiy: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR
 * Image:PDB_1okv_EBI.jpg|1okv: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ILE-PHE-NH2
 * Image:PDB_1okw_EBI.jpg|1okw: CYCLIN A BINDING GROOVE INHIBITOR AC-ARG-ARG-LEU-ASN-(M-CL-PHE)-NH2
 * Image:PDB_1ol1_EBI.jpg|1ol1: CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F-PHE)-NH2
 * Image:PDB_1ol2_EBI.jpg|1ol2: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F-PHE)-NH2
 * Image:PDB_1p2a_EBI.jpg|1p2a: The structure of cyclin dependent kinase 2 (CKD2) with a trisubstituted naphthostyril inhibitor
 * Image:PDB_1p5e_EBI.jpg|1p5e: The strucure of phospho-CDK2/cyclin A in complex with the inhibitor 4,5,6,7-tetrabromobenzotriazole (TBS)
 * Image:PDB_1pf8_EBI.jpg|1pf8: Crystal Structure of Human Cyclin-Dependent Kinase 2 Complexed with a Nucleoside Inhibitor
 * Image:PDB_1pkd_EBI.jpg|1pkd: THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A
 * Image:PDB_1pw2_EBI.jpg|1pw2: APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2
 * Image:PDB_1pxi_EBI.jpg|1pxi: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-Dichloro-thiophen-3-yl)-pyrimidin-2-ylamine
 * Image:PDB_1pxj_EBI.jpg|1pxj: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamine
 * Image:PDB_1pxk_EBI.jpg|1pxk: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-Dimethyl-thiazol-5-yl)pyrimidin-2-yl]-N'-hydroxyiminoformamide
 * Image:PDB_1pxl_EBI.jpg|1pxl: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-(4-trifluoromethyl-phenyl)-amine
 * Image:PDB_1pxm_EBI.jpg|1pxm: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 3-[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol
 * Image:PDB_1pxn_EBI.jpg|1pxn: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-[4-(4-Methyl-2-methylamino-thiazol-5-yl)-pyrimidin-2-ylamino]-phenol
 * Image:PDB_1pxo_EBI.jpg|1pxo: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-Amino-4-methyl-thiazol-5-yl)-pyrimidin-2-yl]-(3-nitro-phenyl)-amine
 * Image:PDB_1pxp_EBI.jpg|1pxp: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-Dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-N',N'-dimethyl-benzene-1,4-diamine
 * Image:PDB_1pye_EBI.jpg|1pye: Crystal structure of CDK2 with inhibitor
 * Image:PDB_1qmz_EBI.jpg|1qmz: PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX
 * Image:PDB_1r78_EBI.jpg|1r78: CDK2 complex with a 4-alkynyl oxindole inhibitor
 * Image:PDB_1urc_EBI.jpg|1urc: CYCLIN A BINDING GROOVE INHIBITOR ACE-ARG-LYS-LEU-PHE-GLY
 * Image:PDB_1urw_EBI.jpg|1urw: CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE
 * Image:PDB_1v1k_EBI.jpg|1v1k: CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR
 * Image:PDB_1vyw_EBI.jpg|1vyw: STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137
 * Image:PDB_1vyz_EBI.jpg|1vyz: STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227
 * Image:PDB_1w0x_EBI.jpg|1w0x: CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE.
 * Image:PDB_1w8c_EBI.jpg|1w8c: CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY-8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2
 * Image:PDB_1w98_EBI.jpg|1w98: THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E
 * Image:PDB_1wcc_EBI.jpg|1wcc: SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY
 * Image:PDB_1y8y_EBI.jpg|1y8y: Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor
 * Image:PDB_1y91_EBI.jpg|1y91: Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor
 * Image:PDB_1ykr_EBI.jpg|1ykr: Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor
 * Image:PDB_2a0c_EBI.jpg|2a0c: Human CDK2 in complex with olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor
 * Image:PDB_2a4l_EBI.jpg|2a4l: Human cyclin-dependent kinase 2 in complex with roscovitine
 * Image:PDB_2b52_EBI.jpg|2b52: Human cyclin dependent kinase 2 (CDK2) complexed with DPH-042562
 * Image:PDB_2b53_EBI.jpg|2b53: Human cyclin dependent kinase 2 (CDK2) complexed with DIN-234325
 * Image:PDB_2b54_EBI.jpg|2b54: Human cyclin dependent kinase 2 (CKD2)complexed with DIN-232305
 * Image:PDB_2b55_EBI.jpg|2b55: Human cyclin dependent kinase 2 (cdk2) complexed with indenopyraxole DIN-101312
 * Image:PDB_2bhe_EBI.jpg|2bhe: HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO-INDIRUBINE
 * Image:PDB_2bhh_EBI.jpg|2bhh: HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4-HYDROXYPIPERINDINESULFONYL-INDIRUBINE
 * Image:PDB_2bkz_EBI.jpg|2bkz: STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611
 * Image:PDB_2bpm_EBI.jpg|2bpm: STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529
 * Image:PDB_2btr_EBI.jpg|2btr: STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873
 * Image:PDB_2bts_EBI.jpg|2bts: STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032
 * Image:PDB_2c4g_EBI.jpg|2c4g: STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514
 * Image:PDB_2c5n_EBI.jpg|2c5n: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
 * Image:PDB_2c5o_EBI.jpg|2c5o: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
 * Image:PDB_2c5p_EBI.jpg|2c5p:
 * Image:PDB_2c5v_EBI.jpg|2c5v: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
 * Image:PDB_2c5x_EBI.jpg|2c5x: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
 * Image:PDB_2c5y_EBI.jpg|2c5y: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN
 * Image:PDB_2c68_EBI.jpg|2c68: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c69_EBI.jpg|2c69: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c6i_EBI.jpg|2c6i: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c6k_EBI.jpg|2c6k: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c6l_EBI.jpg|2c6l: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c6m_EBI.jpg|2c6m: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c6o_EBI.jpg|2c6o: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2c6t_EBI.jpg|2c6t: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
 * Image:PDB_2cch_EBI.jpg|2cch: THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE
 * Image:PDB_2cci_EBI.jpg|2cci: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6
 * Image:PDB_2cjm_EBI.jpg|2cjm: MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE
 * Image:PDB_2clx_EBI.jpg|2clx: 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS
 * Image:PDB_2duv_EBI.jpg|2duv: Structure of CDK2 with a 3-hydroxychromones
 * Image:PDB_2exm_EBI.jpg|2exm: Human CDK2 in complex with isopentenyladenine
 * Image:PDB_2fvd_EBI.jpg|2fvd: Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor
 * Image:PDB_2g9x_EBI.jpg|2g9x: Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor NU6271
 * Image:PDB_2i40_EBI.jpg|2i40: Cdk2/Cyclin A complexed with a thiophene carboxamide inhibitor
 * Image:PDB_2iw6_EBI.jpg|2iw6: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
 * Image:PDB_2iw8_EBI.jpg|2iw8: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR
 * Image:PDB_2iw9_EBI.jpg|2iw9: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR
 * Image:PDB_2jgz_EBI.png|2jgz: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B
 * Image:PDB_2uue_EBI.jpg|2uue: REPLACE: A STRATEGY FOR ITERATIVE DESIGN OF CYCLIN BINDING GROOVE INHIBITORS